Therapeutic androgen receptor ligands
In the past several years, the concept of tissue-selective nuclear receptor ligands has emerged. This concept has come to fruition with estrogens, with the successful marketing of drugs such as raloxifene. The discovery of raloxifene and other selective estrogen receptor modulators (SERMs) has raise...
Main Authors: | Allan, George F., Sui, Zhihua |
---|---|
Format: | Online |
Language: | English |
Published: |
The Nuclear Receptor Signaling Atlas
2003
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402218/ |
Similar Items
-
A yeast screen system for aromatase inhibitors and ligands for androgen receptor: yeast cells transformed with aromatase and androgen receptor.
by: Mak, P, et al.
Published: (1999) -
Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
by: Kahn, Barbara, et al.
Published: (2014) -
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
by: Narayanan, Ramesh, et al.
Published: (2016) -
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
by: Asim, Mohammad, et al.
Published: (2015) -
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
by: Brothers, Shaun P, et al.
Published: (2010)